Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloidosis | 53 | 2024 | 878 | 18.700 |
Why?
|
Cardiomyopathies | 71 | 2024 | 2057 | 12.620 |
Why?
|
Myocardial Perfusion Imaging | 89 | 2024 | 672 | 11.970 |
Why?
|
Amyloid Neuropathies, Familial | 22 | 2024 | 180 | 8.520 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 68 | 2024 | 1140 | 5.370 |
Why?
|
Positron-Emission Tomography | 104 | 2024 | 6668 | 4.980 |
Why?
|
Prealbumin | 31 | 2024 | 259 | 4.970 |
Why?
|
Coronary Artery Disease | 104 | 2024 | 6569 | 4.650 |
Why?
|
Cardiology | 38 | 2024 | 1702 | 4.560 |
Why?
|
Ethylene Glycols | 8 | 2024 | 198 | 4.030 |
Why?
|
Nuclear Medicine | 21 | 2024 | 262 | 4.010 |
Why?
|
Radiopharmaceuticals | 37 | 2024 | 2736 | 3.560 |
Why?
|
Radionuclide Imaging | 20 | 2024 | 2000 | 3.350 |
Why?
|
Coronary Circulation | 44 | 2024 | 1617 | 3.230 |
Why?
|
Aniline Compounds | 8 | 2024 | 1094 | 2.980 |
Why?
|
Myocardium | 30 | 2024 | 4788 | 2.700 |
Why?
|
Heart | 29 | 2023 | 4444 | 2.670 |
Why?
|
Rubidium Radioisotopes | 20 | 2018 | 97 | 2.490 |
Why?
|
Technetium Tc 99m Pyrophosphate | 7 | 2024 | 52 | 2.430 |
Why?
|
Exercise Test | 39 | 2024 | 2186 | 2.330 |
Why?
|
Fluorodeoxyglucose F18 | 20 | 2024 | 2054 | 2.310 |
Why?
|
Fractional Flow Reserve, Myocardial | 21 | 2024 | 346 | 2.170 |
Why?
|
Echocardiography | 18 | 2024 | 5050 | 2.160 |
Why?
|
Sarcoidosis | 16 | 2019 | 535 | 2.090 |
Why?
|
Cardiac Imaging Techniques | 11 | 2023 | 280 | 1.990 |
Why?
|
Heart Failure | 30 | 2024 | 11883 | 1.960 |
Why?
|
Myocardial Ischemia | 21 | 2023 | 2138 | 1.940 |
Why?
|
Predictive Value of Tests | 43 | 2024 | 15442 | 1.810 |
Why?
|
Heart Diseases | 13 | 2022 | 2819 | 1.710 |
Why?
|
Diphosphates | 6 | 2023 | 89 | 1.630 |
Why?
|
Consensus | 16 | 2024 | 3210 | 1.610 |
Why?
|
Magnetic Resonance Imaging, Cine | 11 | 2024 | 1091 | 1.610 |
Why?
|
Amyloid | 11 | 2024 | 854 | 1.570 |
Why?
|
Ventricular Function, Left | 19 | 2024 | 3941 | 1.430 |
Why?
|
Technetium | 9 | 2023 | 328 | 1.400 |
Why?
|
Cardiovascular Infections | 3 | 2024 | 11 | 1.380 |
Why?
|
Vasodilator Agents | 15 | 2021 | 990 | 1.370 |
Why?
|
Tomography, X-Ray Computed | 46 | 2024 | 20757 | 1.320 |
Why?
|
Coronary Angiography | 37 | 2024 | 4541 | 1.320 |
Why?
|
Societies, Medical | 21 | 2024 | 3966 | 1.280 |
Why?
|
Humans | 315 | 2024 | 767991 | 1.160 |
Why?
|
Stroke Volume | 22 | 2023 | 5624 | 1.110 |
Why?
|
Endocarditis | 4 | 2024 | 352 | 1.090 |
Why?
|
Fluorine Radioisotopes | 2 | 2020 | 425 | 1.070 |
Why?
|
Diagnostic Techniques, Cardiovascular | 4 | 2021 | 153 | 1.030 |
Why?
|
Prognosis | 65 | 2024 | 29979 | 1.020 |
Why?
|
Hyperemia | 4 | 2017 | 224 | 0.980 |
Why?
|
Delphi Technique | 5 | 2024 | 891 | 0.980 |
Why?
|
American Heart Association | 3 | 2021 | 1050 | 0.960 |
Why?
|
Image Interpretation, Computer-Assisted | 11 | 2018 | 3389 | 0.960 |
Why?
|
Image Enhancement | 10 | 2017 | 2880 | 0.910 |
Why?
|
Coronary Vessels | 14 | 2023 | 3124 | 0.900 |
Why?
|
Immunoglobulin Light Chains | 3 | 2024 | 289 | 0.890 |
Why?
|
Radiation Dosage | 9 | 2021 | 1967 | 0.840 |
Why?
|
Perfusion | 17 | 2024 | 1401 | 0.840 |
Why?
|
Molecular Imaging | 6 | 2023 | 827 | 0.820 |
Why?
|
Aged | 106 | 2024 | 171446 | 0.770 |
Why?
|
Tellurium | 2 | 2020 | 23 | 0.760 |
Why?
|
Heart Transplantation | 8 | 2024 | 3301 | 0.750 |
Why?
|
Ventricular Dysfunction, Left | 12 | 2020 | 2145 | 0.750 |
Why?
|
Cadmium | 3 | 2022 | 217 | 0.730 |
Why?
|
Amyloidogenic Proteins | 3 | 2023 | 153 | 0.720 |
Why?
|
Image Processing, Computer-Assisted | 16 | 2024 | 9016 | 0.720 |
Why?
|
Coronavirus Infections | 8 | 2020 | 3115 | 0.710 |
Why?
|
Pneumonia, Viral | 8 | 2020 | 3238 | 0.700 |
Why?
|
Pandemics | 17 | 2024 | 8748 | 0.680 |
Why?
|
Middle Aged | 118 | 2024 | 223422 | 0.670 |
Why?
|
Purines | 2 | 2013 | 615 | 0.650 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2024 | 646 | 0.650 |
Why?
|
Leukocytes | 2 | 2024 | 2035 | 0.640 |
Why?
|
Male | 140 | 2024 | 364641 | 0.640 |
Why?
|
Laboratories, Hospital | 1 | 2020 | 192 | 0.630 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2024 | 1751 | 0.620 |
Why?
|
Subtraction Technique | 6 | 2013 | 517 | 0.620 |
Why?
|
Aortitis | 2 | 2016 | 77 | 0.610 |
Why?
|
Myocarditis | 4 | 2023 | 802 | 0.600 |
Why?
|
Female | 143 | 2024 | 397113 | 0.600 |
Why?
|
Microcirculation | 9 | 2023 | 1281 | 0.590 |
Why?
|
Zinc | 3 | 2022 | 677 | 0.590 |
Why?
|
Magnetic Resonance Imaging | 17 | 2024 | 36742 | 0.580 |
Why?
|
Reproducibility of Results | 27 | 2024 | 20218 | 0.540 |
Why?
|
Women's Health | 2 | 2016 | 2082 | 0.540 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 898 | 0.520 |
Why?
|
Patient-Centered Care | 5 | 2021 | 1444 | 0.520 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2022 | 843 | 0.510 |
Why?
|
Microvessels | 3 | 2015 | 585 | 0.510 |
Why?
|
Registries | 24 | 2024 | 8377 | 0.500 |
Why?
|
Practice Guidelines as Topic | 10 | 2021 | 7445 | 0.490 |
Why?
|
Heart Atria | 4 | 2021 | 1361 | 0.480 |
Why?
|
Peptide Fragments | 2 | 2024 | 5151 | 0.480 |
Why?
|
Biopsy | 8 | 2021 | 6786 | 0.470 |
Why?
|
Heart Ventricles | 7 | 2024 | 3841 | 0.470 |
Why?
|
Dementia | 2 | 2020 | 2740 | 0.470 |
Why?
|
Pericarditis | 1 | 2016 | 136 | 0.470 |
Why?
|
Cardiovascular System | 2 | 2021 | 841 | 0.450 |
Why?
|
Diagnostic Imaging | 10 | 2020 | 3532 | 0.450 |
Why?
|
Dipyridamole | 2 | 2011 | 143 | 0.450 |
Why?
|
Ammonia | 6 | 2023 | 247 | 0.440 |
Why?
|
Aortic Valve Stenosis | 3 | 2022 | 2032 | 0.440 |
Why?
|
Myocardial Infarction | 13 | 2024 | 11519 | 0.430 |
Why?
|
Technetium Tc 99m Sestamibi | 9 | 2022 | 184 | 0.430 |
Why?
|
Evidence-Based Medicine | 8 | 2021 | 3701 | 0.430 |
Why?
|
Cardiovascular Diseases | 12 | 2022 | 15660 | 0.420 |
Why?
|
Risk Assessment | 30 | 2024 | 24314 | 0.410 |
Why?
|
Medical Informatics | 1 | 2020 | 743 | 0.410 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2012 | 31 | 0.400 |
Why?
|
Pyrazoles | 2 | 2013 | 2028 | 0.400 |
Why?
|
Societies, Scientific | 1 | 2013 | 223 | 0.390 |
Why?
|
Heart Neoplasms | 2 | 2019 | 374 | 0.370 |
Why?
|
Heart Defects, Congenital | 2 | 2019 | 4713 | 0.350 |
Why?
|
Myocardial Revascularization | 4 | 2014 | 795 | 0.350 |
Why?
|
Laboratories | 4 | 2022 | 463 | 0.350 |
Why?
|
Preventive Health Services | 1 | 2015 | 570 | 0.350 |
Why?
|
Sensitivity and Specificity | 18 | 2024 | 14718 | 0.340 |
Why?
|
Coronary Disease | 8 | 2019 | 5919 | 0.340 |
Why?
|
United States | 26 | 2024 | 73027 | 0.340 |
Why?
|
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 2 | 2020 | 6 | 0.340 |
Why?
|
Aged, 80 and over | 27 | 2024 | 59598 | 0.340 |
Why?
|
Prospective Studies | 21 | 2024 | 54924 | 0.330 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2009 | 47 | 0.320 |
Why?
|
Risk Factors | 37 | 2024 | 74936 | 0.310 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2336 | 0.310 |
Why?
|
Ventricular Remodeling | 3 | 2022 | 1281 | 0.300 |
Why?
|
Stress, Physiological | 3 | 2018 | 1409 | 0.300 |
Why?
|
Military Personnel | 1 | 2017 | 1261 | 0.300 |
Why?
|
Calcinosis | 3 | 2012 | 1481 | 0.300 |
Why?
|
Blood Flow Velocity | 5 | 2017 | 1375 | 0.300 |
Why?
|
Technetium Tc 99m Medronate | 2 | 2018 | 136 | 0.290 |
Why?
|
Unnecessary Procedures | 3 | 2015 | 412 | 0.290 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2023 | 856 | 0.290 |
Why?
|
Decision Making | 6 | 2015 | 3952 | 0.290 |
Why?
|
Paraganglioma | 1 | 2009 | 143 | 0.280 |
Why?
|
Coronary Stenosis | 7 | 2018 | 802 | 0.280 |
Why?
|
Ethics, Medical | 3 | 2015 | 785 | 0.260 |
Why?
|
Radioisotopes | 2 | 2020 | 517 | 0.260 |
Why?
|
Forecasting | 3 | 2015 | 2945 | 0.260 |
Why?
|
Organotechnetium Compounds | 3 | 2020 | 132 | 0.250 |
Why?
|
Adenosine | 3 | 2011 | 820 | 0.250 |
Why?
|
Atherosclerosis | 2 | 2021 | 3433 | 0.250 |
Why?
|
Quality Control | 4 | 2020 | 836 | 0.240 |
Why?
|
Time Factors | 16 | 2024 | 40214 | 0.240 |
Why?
|
Cause of Death | 6 | 2018 | 3720 | 0.240 |
Why?
|
Prosthesis-Related Infections | 2 | 2024 | 497 | 0.240 |
Why?
|
Blood Pressure | 5 | 2016 | 8540 | 0.240 |
Why?
|
Contrast Media | 3 | 2021 | 5330 | 0.240 |
Why?
|
Early Diagnosis | 2 | 2020 | 1193 | 0.240 |
Why?
|
Heart Rate | 3 | 2014 | 4215 | 0.240 |
Why?
|
Retrospective Studies | 30 | 2024 | 81746 | 0.240 |
Why?
|
Angina, Unstable | 2 | 2019 | 893 | 0.230 |
Why?
|
Echocardiography, Stress | 1 | 2005 | 138 | 0.230 |
Why?
|
Perfusion Imaging | 2 | 2020 | 195 | 0.220 |
Why?
|
Patient Selection | 5 | 2022 | 4258 | 0.220 |
Why?
|
Chest Pain | 4 | 2021 | 1101 | 0.210 |
Why?
|
Regional Blood Flow | 2 | 2018 | 1500 | 0.210 |
Why?
|
Multiple Myeloma | 1 | 2021 | 5196 | 0.210 |
Why?
|
Quality of Life | 1 | 2024 | 13489 | 0.210 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 37 | 0.200 |
Why?
|
Cohort Studies | 13 | 2023 | 41749 | 0.200 |
Why?
|
Troponin I | 1 | 2007 | 662 | 0.200 |
Why?
|
Severity of Illness Index | 11 | 2024 | 15944 | 0.200 |
Why?
|
Calcium | 4 | 2020 | 5794 | 0.200 |
Why?
|
Radiation Protection | 2 | 2016 | 428 | 0.190 |
Why?
|
Electrocardiography | 10 | 2015 | 6411 | 0.190 |
Why?
|
Hypertension | 5 | 2024 | 8616 | 0.190 |
Why?
|
Diabetic Angiopathies | 2 | 2019 | 806 | 0.190 |
Why?
|
Electric Countershock | 1 | 2024 | 534 | 0.190 |
Why?
|
Medicare | 1 | 2019 | 6809 | 0.180 |
Why?
|
Bone and Bones | 2 | 2024 | 2589 | 0.180 |
Why?
|
Adult | 30 | 2022 | 223583 | 0.180 |
Why?
|
Sodium Fluoride | 1 | 2021 | 67 | 0.180 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14783 | 0.180 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2298 | 0.170 |
Why?
|
Prevalence | 8 | 2022 | 15867 | 0.170 |
Why?
|
Awards and Prizes | 2 | 2022 | 365 | 0.170 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2005 | 519 | 0.170 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1126 | 0.170 |
Why?
|
Follow-Up Studies | 18 | 2022 | 39345 | 0.170 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5366 | 0.170 |
Why?
|
Mediastinum | 1 | 2021 | 272 | 0.170 |
Why?
|
Vasodilation | 4 | 2012 | 968 | 0.170 |
Why?
|
Gamma Cameras | 1 | 2019 | 35 | 0.160 |
Why?
|
Thallium Radioisotopes | 1 | 2019 | 139 | 0.160 |
Why?
|
Death, Sudden, Cardiac | 4 | 2018 | 1567 | 0.160 |
Why?
|
General Practitioners | 1 | 2020 | 103 | 0.160 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2019 | 83 | 0.160 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2020 | 193 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2023 | 3780 | 0.160 |
Why?
|
Software | 6 | 2021 | 4478 | 0.160 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5520 | 0.150 |
Why?
|
Knowledge | 1 | 2020 | 178 | 0.150 |
Why?
|
Cardiovascular Agents | 2 | 2017 | 849 | 0.150 |
Why?
|
Survival Rate | 7 | 2019 | 12828 | 0.150 |
Why?
|
Finland | 1 | 2019 | 609 | 0.150 |
Why?
|
Receptors, Somatostatin | 1 | 2019 | 138 | 0.150 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 769 | 0.150 |
Why?
|
Exercise | 2 | 2013 | 5955 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 242 | 0.150 |
Why?
|
Echocardiography, Transesophageal | 1 | 2024 | 1096 | 0.150 |
Why?
|
Parotid Gland | 1 | 2019 | 178 | 0.150 |
Why?
|
Thoracic Neoplasms | 1 | 2020 | 269 | 0.150 |
Why?
|
Pilot Projects | 3 | 2023 | 8740 | 0.150 |
Why?
|
Death Certificates | 1 | 2018 | 172 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.140 |
Why?
|
Diagnosis, Differential | 8 | 2020 | 13000 | 0.140 |
Why?
|
Heart Failure, Diastolic | 1 | 2018 | 77 | 0.140 |
Why?
|
ROC Curve | 7 | 2024 | 3628 | 0.140 |
Why?
|
Exercise Tolerance | 2 | 2020 | 846 | 0.140 |
Why?
|
Waiting Lists | 1 | 2022 | 779 | 0.140 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2020 | 511 | 0.140 |
Why?
|
Mass Media | 1 | 2020 | 303 | 0.140 |
Why?
|
Coronary Artery Bypass | 3 | 2014 | 2191 | 0.130 |
Why?
|
Radioactive Tracers | 2 | 2020 | 68 | 0.130 |
Why?
|
Systole | 1 | 2018 | 937 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6843 | 0.130 |
Why?
|
Treatment Outcome | 13 | 2024 | 65364 | 0.130 |
Why?
|
Proportional Hazards Models | 9 | 2016 | 12536 | 0.130 |
Why?
|
Paraproteinemias | 2 | 2020 | 252 | 0.130 |
Why?
|
Public Opinion | 1 | 2020 | 485 | 0.130 |
Why?
|
Calibration | 1 | 2018 | 819 | 0.130 |
Why?
|
Algorithms | 6 | 2024 | 14163 | 0.130 |
Why?
|
Organometallic Compounds | 1 | 2019 | 648 | 0.130 |
Why?
|
Troponin | 2 | 2018 | 536 | 0.120 |
Why?
|
Tissue Distribution | 1 | 2019 | 2299 | 0.120 |
Why?
|
Obesity, Morbid | 1 | 2006 | 1298 | 0.120 |
Why?
|
Protein Folding | 1 | 2018 | 871 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2022 | 1334 | 0.120 |
Why?
|
Fibrosis | 2 | 2023 | 2080 | 0.120 |
Why?
|
Autoradiography | 1 | 2015 | 727 | 0.120 |
Why?
|
Decision Trees | 1 | 2016 | 508 | 0.120 |
Why?
|
Safety Management | 1 | 2020 | 765 | 0.120 |
Why?
|
Fee-for-Service Plans | 1 | 2019 | 713 | 0.110 |
Why?
|
North America | 4 | 2020 | 1289 | 0.110 |
Why?
|
Gated Blood-Pool Imaging | 2 | 2007 | 44 | 0.110 |
Why?
|
Age Distribution | 2 | 2018 | 2871 | 0.110 |
Why?
|
Vasomotor System | 1 | 2014 | 208 | 0.110 |
Why?
|
Safety | 2 | 2021 | 1159 | 0.110 |
Why?
|
Gadolinium | 1 | 2018 | 964 | 0.110 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2016 | 263 | 0.110 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3414 | 0.110 |
Why?
|
Remission Induction | 1 | 2019 | 2409 | 0.110 |
Why?
|
Pulse | 1 | 2013 | 218 | 0.100 |
Why?
|
Physics | 1 | 2013 | 92 | 0.100 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5887 | 0.100 |
Why?
|
Critical Pathways | 1 | 2016 | 476 | 0.100 |
Why?
|
Risk | 7 | 2021 | 9609 | 0.100 |
Why?
|
Blood Coagulation | 1 | 1998 | 1162 | 0.100 |
Why?
|
Benzoxazoles | 2 | 2024 | 92 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2021 | 22287 | 0.100 |
Why?
|
Obesity | 6 | 2024 | 13091 | 0.100 |
Why?
|
Psoriasis | 1 | 2020 | 926 | 0.100 |
Why?
|
Fibroblasts | 1 | 2022 | 4176 | 0.100 |
Why?
|
Defibrillators, Implantable | 2 | 2018 | 1499 | 0.100 |
Why?
|
Lower Extremity | 1 | 2020 | 1216 | 0.100 |
Why?
|
Autopsy | 1 | 2015 | 1011 | 0.090 |
Why?
|
Young Adult | 5 | 2019 | 60048 | 0.090 |
Why?
|
Myocardial Stunning | 1 | 2011 | 67 | 0.090 |
Why?
|
Tissue Survival | 1 | 2011 | 120 | 0.090 |
Why?
|
Death | 2 | 2012 | 683 | 0.090 |
Why?
|
Europe | 4 | 2021 | 3437 | 0.090 |
Why?
|
Documentation | 2 | 2017 | 917 | 0.090 |
Why?
|
Feasibility Studies | 3 | 2023 | 5314 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 4 | 2018 | 2258 | 0.090 |
Why?
|
Body Mass Index | 3 | 2014 | 13053 | 0.090 |
Why?
|
Incidence | 5 | 2021 | 21532 | 0.090 |
Why?
|
Hemodynamics | 3 | 2013 | 4194 | 0.090 |
Why?
|
Physicians, Women | 2 | 2024 | 516 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2015 | 812 | 0.090 |
Why?
|
Physicians | 2 | 2022 | 4598 | 0.090 |
Why?
|
Kidney Failure, Chronic | 2 | 2015 | 2496 | 0.090 |
Why?
|
Systems Integration | 3 | 2007 | 430 | 0.090 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2665 | 0.090 |
Why?
|
Regeneration | 1 | 2019 | 1524 | 0.080 |
Why?
|
Fasting | 1 | 2016 | 1609 | 0.080 |
Why?
|
Hospitals | 2 | 2020 | 3886 | 0.080 |
Why?
|
Biological Transport | 1 | 2014 | 2085 | 0.080 |
Why?
|
Coronary Aneurysm | 1 | 2012 | 234 | 0.080 |
Why?
|
Organ Specificity | 1 | 2014 | 1968 | 0.080 |
Why?
|
Boston | 3 | 2019 | 9368 | 0.080 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2018 | 1077 | 0.080 |
Why?
|
Causality | 1 | 2015 | 1254 | 0.080 |
Why?
|
Bone Marrow | 1 | 2019 | 2935 | 0.080 |
Why?
|
Radiation Injuries | 2 | 2014 | 1198 | 0.080 |
Why?
|
Canada | 2 | 2021 | 2129 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2165 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4261 | 0.080 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 1119 | 0.080 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8052 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2570 | 0.080 |
Why?
|
3-Iodobenzylguanidine | 1 | 2009 | 115 | 0.080 |
Why?
|
Comorbidity | 4 | 2018 | 10590 | 0.080 |
Why?
|
Nitrogen Radioisotopes | 2 | 2018 | 44 | 0.070 |
Why?
|
Adolescent | 6 | 2019 | 89155 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2020 | 3573 | 0.070 |
Why?
|
Survival Analysis | 5 | 2017 | 10098 | 0.070 |
Why?
|
Latin America | 2 | 2022 | 416 | 0.070 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5182 | 0.070 |
Why?
|
Multivariate Analysis | 7 | 2016 | 12075 | 0.070 |
Why?
|
Recovery of Function | 2 | 2017 | 2981 | 0.070 |
Why?
|
Ischemia | 3 | 2020 | 1900 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2020 | 5349 | 0.070 |
Why?
|
Heart Valve Prosthesis | 1 | 2015 | 1468 | 0.070 |
Why?
|
Angiography | 1 | 2012 | 1597 | 0.070 |
Why?
|
Whole Body Imaging | 1 | 2009 | 284 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1885 | 0.070 |
Why?
|
Bundle-Branch Block | 1 | 2008 | 280 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6495 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2015 | 1791 | 0.060 |
Why?
|
Infection Control | 1 | 2013 | 985 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2012 | 993 | 0.060 |
Why?
|
Catheter Ablation | 1 | 1998 | 2787 | 0.060 |
Why?
|
Chi-Square Distribution | 4 | 2016 | 3435 | 0.060 |
Why?
|
Myocardial Reperfusion | 1 | 2006 | 339 | 0.060 |
Why?
|
Thrombosis | 1 | 1998 | 2957 | 0.060 |
Why?
|
Sex Factors | 3 | 2024 | 10627 | 0.060 |
Why?
|
Hospitalization | 3 | 2019 | 10840 | 0.060 |
Why?
|
Spain | 2 | 2015 | 484 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 26375 | 0.060 |
Why?
|
Health Care Surveys | 2 | 2021 | 2433 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2166 | 0.050 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1793 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2019 | 10470 | 0.050 |
Why?
|
Linear Models | 3 | 2016 | 5884 | 0.050 |
Why?
|
Protein Binding | 1 | 2015 | 9343 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9252 | 0.050 |
Why?
|
Apoptosis | 1 | 2019 | 9521 | 0.050 |
Why?
|
Arterial Occlusive Diseases | 1 | 2007 | 744 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2650 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6517 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2014 | 6228 | 0.050 |
Why?
|
Insurance Coverage | 1 | 2013 | 1946 | 0.050 |
Why?
|
Ultrasonography | 1 | 2015 | 6004 | 0.050 |
Why?
|
Mass Spectrometry | 2 | 2020 | 2202 | 0.050 |
Why?
|
Physician's Role | 1 | 2008 | 925 | 0.050 |
Why?
|
Benzothiazoles | 1 | 2022 | 248 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2017 | 12464 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3463 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2024 | 563 | 0.050 |
Why?
|
Lung | 1 | 2019 | 10094 | 0.050 |
Why?
|
Leadership | 2 | 2020 | 1397 | 0.040 |
Why?
|
Phenotype | 1 | 2018 | 16723 | 0.040 |
Why?
|
Glomerular Filtration Rate | 3 | 2017 | 2227 | 0.040 |
Why?
|
International Agencies | 1 | 2021 | 244 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6983 | 0.040 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2020 | 171 | 0.040 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 1551 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2010 | 2008 | 0.040 |
Why?
|
Radiology | 1 | 2013 | 2104 | 0.040 |
Why?
|
Myocardial Contraction | 1 | 2005 | 1525 | 0.040 |
Why?
|
Disease Management | 2 | 2020 | 2533 | 0.040 |
Why?
|
Italy | 1 | 2021 | 856 | 0.040 |
Why?
|
Area Under Curve | 2 | 2014 | 1642 | 0.040 |
Why?
|
Organ Size | 1 | 2024 | 2267 | 0.040 |
Why?
|
Israel | 1 | 2021 | 726 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2022 | 540 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 311 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1127 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4055 | 0.040 |
Why?
|
Technology | 1 | 2021 | 296 | 0.040 |
Why?
|
Electroencephalography | 1 | 2014 | 6311 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2599 | 0.040 |
Why?
|
Prothrombin | 1 | 1998 | 194 | 0.040 |
Why?
|
Referral and Consultation | 3 | 2015 | 3619 | 0.040 |
Why?
|
Probability | 2 | 2014 | 2479 | 0.040 |
Why?
|
Pregnancy | 2 | 2013 | 30260 | 0.040 |
Why?
|
Age Factors | 3 | 2024 | 18407 | 0.040 |
Why?
|
Models, Cardiovascular | 2 | 2013 | 981 | 0.040 |
Why?
|
Fibrinolysis | 1 | 1998 | 331 | 0.040 |
Why?
|
Vascular Resistance | 2 | 2011 | 939 | 0.030 |
Why?
|
Massachusetts | 3 | 2015 | 8888 | 0.030 |
Why?
|
Communication | 3 | 2015 | 3904 | 0.030 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 211 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1013 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2003 | 1724 | 0.030 |
Why?
|
Oceania | 1 | 2016 | 21 | 0.030 |
Why?
|
Child, Preschool | 1 | 2019 | 42665 | 0.030 |
Why?
|
Patient Participation | 2 | 2015 | 1446 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 467 | 0.030 |
Why?
|
Thrombin | 1 | 1998 | 600 | 0.030 |
Why?
|
Pyridazines | 1 | 2017 | 203 | 0.030 |
Why?
|
Antithrombins | 1 | 1998 | 294 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1743 | 0.030 |
Why?
|
Automation | 1 | 2018 | 589 | 0.030 |
Why?
|
Expert Testimony | 1 | 2017 | 266 | 0.030 |
Why?
|
Electrophysiology | 1 | 1998 | 1266 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 698 | 0.030 |
Why?
|
Kidney | 2 | 2023 | 7065 | 0.030 |
Why?
|
Body Weight | 1 | 2006 | 4628 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
Health Services | 1 | 2020 | 755 | 0.030 |
Why?
|
Diastole | 1 | 2017 | 785 | 0.030 |
Why?
|
Sex Distribution | 2 | 2014 | 2276 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 788 | 0.030 |
Why?
|
Asia | 1 | 2016 | 629 | 0.030 |
Why?
|
Nitroglycerin | 1 | 2015 | 332 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21206 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2019 | 1564 | 0.030 |
Why?
|
Computer Systems | 1 | 2015 | 469 | 0.030 |
Why?
|
Observer Variation | 2 | 2013 | 2618 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1395 | 0.030 |
Why?
|
Africa | 1 | 2016 | 725 | 0.030 |
Why?
|
Logistic Models | 3 | 2016 | 13289 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 724 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 812 | 0.030 |
Why?
|
Animals | 5 | 2019 | 169222 | 0.030 |
Why?
|
Radiotherapy | 1 | 2020 | 1501 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2020 | 2916 | 0.030 |
Why?
|
Japan | 1 | 2017 | 1418 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2014 | 252 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2018 | 1527 | 0.030 |
Why?
|
Tachycardia, Ventricular | 2 | 2013 | 1311 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 962 | 0.030 |
Why?
|
Angioplasty | 1 | 2015 | 355 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 8082 | 0.020 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2015 | 281 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1970 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 828 | 0.020 |
Why?
|
Acute Disease | 2 | 2012 | 7241 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2863 | 0.020 |
Why?
|
Sulfonic Acids | 1 | 2011 | 103 | 0.020 |
Why?
|
Child | 1 | 2019 | 80906 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2107 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4938 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 590 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 772 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2011 | 279 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2014 | 1104 | 0.020 |
Why?
|
Acetates | 1 | 2011 | 317 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2020 | 1807 | 0.020 |
Why?
|
Internationality | 1 | 2015 | 1008 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 1001 | 0.020 |
Why?
|
Acetamides | 1 | 2011 | 259 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2012 | 542 | 0.020 |
Why?
|
Pericardium | 1 | 2014 | 681 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6894 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1434 | 0.020 |
Why?
|
Data Collection | 1 | 2018 | 3326 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2009 | 458 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4564 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3385 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3036 | 0.020 |
Why?
|
Postoperative Care | 1 | 2014 | 1480 | 0.020 |
Why?
|
Negotiating | 1 | 2008 | 152 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2009 | 684 | 0.020 |
Why?
|
Syncope | 1 | 2010 | 430 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 2120 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2011 | 2708 | 0.020 |
Why?
|
Inflammation | 2 | 2018 | 10871 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1321 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2357 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 13042 | 0.020 |
Why?
|
Job Satisfaction | 1 | 2008 | 548 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1883 | 0.010 |
Why?
|
Prejudice | 1 | 2008 | 574 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2011 | 972 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13665 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5536 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9666 | 0.010 |
Why?
|
Mentors | 1 | 2008 | 671 | 0.010 |
Why?
|
Rest | 1 | 2008 | 948 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2914 | 0.010 |
Why?
|
Sulfonamides | 1 | 2011 | 1982 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2923 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2012 | 1947 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 577 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8507 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2005 | 2227 | 0.010 |
Why?
|
Radionuclide Angiography | 1 | 1999 | 23 | 0.010 |
Why?
|
Acute Coronary Syndrome | 1 | 2012 | 2194 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18344 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3858 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23751 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9384 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30211 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27366 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3929 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2003 | 15831 | 0.000 |
Why?
|